1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
61A848DC428A7C0C800258B6C004C18A6
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/building-more-effective-medical-affairs-product-launch-teams-cns-neurosciences-segment
18
19
20172.70.130.63
21
22
23527255.sherryhk.tech
24/bestp/domrep.nsf
25BMR
Access. Intelligence. Excellence

| Advanced Search | 0
Research and Consulting Areas of Expertise

Benchmarking Reports Areas of Expertise Report Catalog FAQ
Best Practice Database Areas of Expertise New Research Case Analogs Benefits Types Of Research Current Members
Research and Advisory Services Areas of Expertise Digital Technology Consortium Field Medical Excellence Medical Affairs Consortium White Papers Research Partners Partnership Benefits Contact Us
Excellence Services Pharma and Medical Device Quality New Product Planning Medical Affairs Pharmaceutical Launch Market Research Competitive Intelligence

Industries

Biotechnology Financial Services Healthcare Medical Device Manufacturing Pharmaceuticals Technology and Communications

Functions

Brand Management & Product Leadership Competitive & Business Intelligence Commercial Operations Customer Service Clinical Operations Digital Technologies / AI Human Resources Medical Affairs Market Access Market Research, Analytics & Forecasting

 

Marketing Management Patient Access, Support, Insights and Operations Product Launch Pull Through Pharma Launch Playbook Scenario Planning / War Gaming Sales Supply Chain
Corporate Overview About Benchmarking Benchmarking Books What is a Best Practice? Research Methodology

Our Clients Testimonials

Our Team Careers Best Practices Interns Work at Best Practices, LLC Help Set Research Agenda
Follow Best Practices LLC linkedIn twitter slideshare youtube pinterest

Overview Press Releases Speaking Events Media Coverage Receive Research Updates Contact Us
Address/Email/Phone Schedule a Meeting
Report Catalog Videos
Database Member Home RAS Member Home

» Products & Services » » Medical Affairs » Launch Optimization

Building More Effective Medical Affairs Product Launch Teams: CNS / Neurosciences Segment

Medical Affairs Product Launch in CNS / Neurosciences Segment

Download FREE Excerpt

ID: POP-386

Features:

12 Info Graphics

32 Data Graphics

660+ Metrics

18 Narratives

Pages: 56

Published: 2024

Delivery Format: Shipped

 

License Options:


Buy Now

 

919-403-0251
Schedule a Meeting

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
Medical Affairs plays a pivotal role in the rapidly growing and transforming CNS market, where product launches demand innovative and high-impact strategies. However, some organizations fail to understand how Medical Affairs can best support CNS and Neurosciences product launches, lacking well-defined success metrics for effectively evaluating launch performance and judging optimal resource allocation to key activities.

Best Practices, LLC conducted this benchmarking research to uncover critical insights into the evolving role of Medical Affairs in CNS and Neurosciences product launches. The report examines the shifting responsibilities of Medical Affairs, the importance of cross-functional alignment, key performance metrics, strategic resource allocation, activity effectiveness, and essential launch timelines. Additionally, this research scrutinizes the strategic utilization of digital tools tailored to cater to the specific needs of CNS and Neurosciences customers and stakeholders. The report also pinpoints key success factors and challenges that are imperative for achieving best-in-class launch preparedness in this dynamic and complex market.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Diagnostic; Chemical; Health Care; Consulting; Communications; Consumer Products; Medical Device


Companies Profiled:
Adamas Pharmaceuticals; Apellis Pharmaceuticals; AstraZeneca; BELLUS Health; BIAL; bioMerieux; Boehringer Ingelheim; EMD Serono; Eurofarma; Genentech; Gedeon Richter ; GW Pharmaceuticals; Ipsen; Kyowa Kirin; Labaid Group; Lundbeck; MEDiSTRAVA; Merck KGaA; NexGen Healthcare Communications; Novartis; Pixacore; Sandoz; Sunovion; Takeda Pharmaceuticals; Terumo BCT: Terumo Blood and Cell Technologies

Study Snapshot

Best Practices, LLC engaged 30 Medical leaders from 25 leading life sciences companies in this benchmarking research study. Directors and upper management executives represent nearly four-fifths of the leaders who shared data and insights on Medical launch activities in this study.

Key topics covered in this report include:

  • Medical Leadership Roles and Launch Activity Effectiveness in CNS / Neurosciences
  • Ensuring Cross-functional Alignment and Collaboration in CNS / Neurosciences Launches
  • Medical Launch Evolution in CNS / Neurosciences Segment
  • CNS / Neurosciences Launch Activities Timeline, Performance Tracking, and Resourcing
  • Critical Success Factors and Major Pitfalls for Medical Affairs During CNS / Neurosciences Launches
  • Digital Launch Implementation and Impact in CNS / Neurosciences
  • Launch Tool Deployment for CNS / Neurosciences Products

Key Findings

Select key insights uncovered from this report are noted below. Detailed findings are available in the full report.
  • Digital Launch Tools: In the CNS / Neurosciences segment, digital tools are pivotal for Medical Affairs' launch strategies. Key tools include platforms like Veeva, Zoom, Microsoft Teams, and Smartsheet for digital communications, which facilitate stakeholder coordination. Insights collection software, such as Kernel, is used to gather and analyze data, providing crucial market insights. Social platforms like Facebook, LinkedIn, and X (formerly Twitter) are leveraged for information dissemination and engagement. Additionally, tools like 60 Seconds and Monocl enhance MSL engagement by supporting training and interactions. These tools collectively modernize operations and optimize launch strategies in the CNS / Neurosciences market.
Table of Contents

Sr. No.
Topic
Slide No.
I.
Executive SummaryPg. 4
II.
Section I: Launch Excellence and Medical’s Role & Activity EffectivenessPg. 6-12
III.
Section II: Ensuring Cross-functional Alignment and CollaborationPg. 13-15
IV.
Section III: Adopting to Ongoing Changes in Medical LandscapePg. 16-20
V.
Section IV: Launch Timeline, Preparedness Metrics, and ResourcingPg. 21-26
VI.
Section V: Critical Success Factors and Major PitfallsPg. 27-32
VII.
Section VI: Digital Influence on Launch Processes and Launch Tool DeploymentPg. 33-41
VIII.
Section VII: Participant DemographicsPg. 42-43
IX.
Section VIII: Detailed Benchmark Study DataPg. 44-55
X.
Section IX: About Best Practices, LLCPg. 56

    List of Charts & Exhibits

    I. Launch Excellence and Medical’s Role & Activity Effectiveness
    • Framework for Medical launch excellence
    • Role of Medical Affairs in CNS / Neurosciences launches
    • Medical leadership roles in CNS / Neurosciences launches
    • Effectiveness of Medical Affairs in CNS / Neurosciences launch activities
    • Most effective launch activities for Medical Affairs in CNS / Neurosciences
    • Improvement opportunities for Medical Affairs around CNS / Neurosciences launch activities

    II. Ensuring Cross-functional Alignment and Collaboration
    • Medical Affairs’ collaboration with internal teams for CNS / Neurosciences launches
    • Role of Medical Affairs in cross-functional CNS / Neurosciences teams

    III. Adopting to Ongoing Changes in Medical Landscape
    • Evolution of Medical launch strategies
    • Medical’s advances in digital data dissemination and communication
    • Medical’s advances in education approaches
    • Changes in Medical’s organizational support for launches

    IV. Launch Timeline, Preparedness Metrics and Resourcing
    • Timeline of Medical Affairs’ launch activities in CNS / Neurosciences
    • Medical Affairs’ annual investment and FTE allocation for CNS / Neurosciences launches
    • Utilization of launch dashboards and information
    • Allocation of Medical Affairs investment to CNS / Neurosciences launch activities
    • Allocation of Medical Affairs FTEs to CNS / Neurosciences launch activities

    V. Critical Success Factors and Major Pitfalls
    • Key success factors for Medical Affairs in CNS / Neurosciences launches
    • Areas where advanced team planning is important for CNS / Neurosciences launches
    • Six essential areas for successful Medical Affairs’ launch readiness in CNS / Neurosciences
    • Major pitfalls for Medical Affairs during CNS / Neurosciences launches
    • Six major challenge areas for Medical Affairs during CNS / Neurosciences launches

    VI. Digital Influence on Launch Processes and Launch Tool Deployment
    • Post-pandemic digital technology utilization in Medical Affairs during CNS / Neurosciences product launches
    • Impact of digital technologies on current and future CNS / Neurosciences launch processes
    • Digital tools deployed by Medical Affairs during the CNS / Neurosciences product launch cycle
    • Impact of top three digital activities led by Medical Affairs in CNS / Neurosciences
    • Effectiveness of digital activities and programs in supporting a successful CNS / Neurosciences product launch
    • Leading digital tools for Medical Affairs’ launch success
    • Emerging digital tools affecting Medical’s launch strategies
    • Example of a valuable digital tool supporting launch activities

    VII. Participant Demographics
    • Geographic responsibility of benchmark partners

    VIII. Detailed Benchmark Study Data
    • Role served by Medical Affairs in CNS / Neurosciences product launches
    • Effectiveness of Medical Affairs’ roles in CNS / Neurosciences launches
    • Role served by Medical Affairs in planning, research, and education activities in CNS / Neurosciences segment
    • Role served by Medical Affairs in data dissemination and organizational support activities in CNS / Neurosciences segment
    • Role served by Medical Affairs in research activities in CNS / Neurosciences segment
    • Role served by Medical Affairs in education and data dissemination support activities in CNS / Neurosciences segment
    • Role served by Medical Affairs in organizational support activities in CNS / Neurosciences segment
    • Timeline for Medical Affairs launch activity involvement - Evidence generation and field-based medical activities in CNS / Neurosciences
    • Timeline for Medical Affairs launch activity involvement - Medical information and medical regulatory activities in CNS / Neurosciences
    • Timeline for Medical Affairs launch activity involvement - HEOR activities and medical / scientific communications in CNS / Neurosciences
    • Timeline for Medical Affairs launch activity involvement - Independent medical education and external engagement activities in CNS / Neurosciences

    RELATED RESEARCH